{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T07:45:25Z","timestamp":1774770325168,"version":"3.50.1"},"reference-count":32,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":4015,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[1997,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\n\t\t\t\t\t<\/jats:bold> The importance of TH<jats:sub>2<\/jats:sub>\u2010type T cell cytokines in atopic disease is widely accepted. CD30, a member of the TNF\/NGF receptor superfamily, is expressed on a proportion of activated CD45RO<jats:sup>+<\/jats:sup> T cells and has been proposed as a marker for TH<jats:sub>2<\/jats:sub> phenotype. CD30 ligand\u2010CD30 interaction has been shown to positively influence development of the TH<jats:sub>2<\/jats:sub> phenotype, and serum levels of soluble CD30 (sCD30) have been used as prognostic markers in HIV, SLE, Epstein\u2010Barr Virus infection and Hodgkin's Lymphoma but not as yet in allergic disease.<\/jats:p><jats:p><jats:bold>Objectives\n\t\t\t\t\t<\/jats:bold> To establish if serum levels of sCD30 are elevated in atopic asthma and determine whether allergen\u2010induced proliferation\/activation of PBMCs from atopic asthmatics promotes CD30 expression on CD4<jats:sup>+<\/jats:sup> T lymphocytes. Further, to determine if expression of CD30 and sCD30 correlate with disease severity.<\/jats:p><jats:p><jats:bold>Methods\n\t\t\t\t\t<\/jats:bold> Eighteen atopic asthmatics were each assigned a symptomatic disease score based on symptoms and bronchodilator rescue usage. Serum sCD30 was measured in peripheral blood by ELISA. PBMCs from atopic asthmatics were analysed with flow cytometry to obtain the proportions of CD<jats:sup>4<\/jats:sup> T cells expressing CD45RO and CD30. The cells were then cultured for 10 days with IL\u20102 with or without house dust mite antigen. A proliferation index was recorded and expression of CD30 and CD45RO retested. As a control, stimulation with PHA was used. Results with patients\u2019 PBMCs were compared with results of a parallel analysis of PBMCs from non\u2010atopic healthy controls.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> Serum sCD30 was elevated in the 18 atopic asthmatics compared with a group of normal subjects but levels did not correlate with symptomatic disease activity. CD4CD45RO expression was low (14%) in atopic asthmatic peripheral blood but increased to 41% after 10 days culture with allergen. The CD4:CD8 ratio increased after Der p stimulation. A significant rise in the percentage of CD4<jats:sup>4<\/jats:sup> T cells expressing surface CD30 (29%) was seen along with increased mean fluorescence intensity. Both these results correlated with symptomatic disease severity score. Non\u2010specific PHA stimulation failed to significantly affect CD30 expression.<\/jats:p><jats:p><jats:bold>Conclusions\n\t\t\t\t\t<\/jats:bold> There is a specific response to allergen in atopic asthma which causes significant increases in CD30 expression. This may correlate with disease severity.<\/jats:p>","DOI":"10.1046\/j.1365-2222.1997.700840.x","type":"journal-article","created":{"date-parts":[[2003,11,6]],"date-time":"2003-11-06T15:52:13Z","timestamp":1068133933000},"page":"780-786","source":"Crossref","is-referenced-by-count":23,"title":["Allergen\u2010induced CD30 expression on T cells of atopic asthmatics"],"prefix":"10.1111","volume":"27","author":[{"given":"C.","family":"LEONARD","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"TORMEY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"FAUL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"BURKE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. W.","family":"POULTER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"66","article-title":"Changing patterns in asthma morbidity and mortality","volume":"5","author":"Sears MR","year":"1995","journal-title":"J Investig Allergol Clin Immunol"},{"key":"e_1_2_1_3_2","first-page":"321","article-title":"US asthma mortality: 1941\u20131989","volume":"74","author":"Arrighi HM","year":"1995","journal-title":"Ann Allergy Asthma Immunol"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1183\/09031936.94.07050981","article-title":"Near fatal asthma","volume":"7","author":"Molfino NA","year":"1994","journal-title":"Eur Resp J"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/142.1.108"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1994.tb00785.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(95)70285-7"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201303260504"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.1.1"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.4049\/jimmunol.144.12.4651","article-title":"Evidence for compartmentalisation of functional subsets of CD4+ T lymphocytes in atopic patients","volume":"144","author":"Wierenga EA","year":"1990","journal-title":"J Immunol"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830220640"},{"key":"e_1_2_1_12_2","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.4049\/jimmunol.148.7.2142","article-title":"Reciprocal regulatory effects of IFN\u2010 and IL\u20104 on the in vitro development of human Thl and Th2 clones","volume":"148","author":"Maggi E","year":"1992","journal-title":"J Immunol"},{"key":"e_1_2_1_13_2","first-page":"251","article-title":"Interleukin\u20104 and soluble CD23 serum levels in asthmatic atopic children","volume":"5","author":"Daher S","year":"1995","journal-title":"J Investig Allergol Clin Immunol"},{"key":"e_1_2_1_14_2","first-page":"81","article-title":"Preferential expression of CD30 by human CD4+ T cells with Th2 phenotype FASEB","volume":"9","author":"Prete G","year":"1995","journal-title":"J Investig Allergol Clin Immunol"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.6.1655"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.1.195"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.1.109"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90361-S"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V85.1.1.bloodjournal8511","article-title":"CD30 (Ki\u20101) molecule: A new cytokine receptor of the TNF receptor superfamily as a tool for diagnosis and immunotherapy","volume":"85","author":"Falini B","year":"1995","journal-title":"Blood"},{"key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood.V63.6.1299.1299","article-title":"A Hodgkin cell\u2010specific antigen is expressed on a subset of auto\u2010and allo\u2010activated T (helper) lymphoblasts","volume":"63","author":"Andreesen R","year":"1984","journal-title":"Blood"},{"key":"e_1_2_1_21_2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.848","article-title":"The expression of the Hodgkin's disease associated antigen Ki\u20101 in reactive and neoplastic lymphoid tissue: evidence that Reed\u2010Stemberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein H","year":"1985","journal-title":"Blood"},{"key":"e_1_2_1_22_2","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.4049\/jimmunol.153.7.2861","article-title":"CD30 defines a subset of cells that produce IFN\u2010gamma & IL\u20105 and exhibit enhanced B cell helper activity","volume":"153","author":"Alzona M","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_1_23_2","first-page":"2861","article-title":"IL\u201012 activates IFN\u2010gamma production through the preferential activation of CD30+ T cells","volume":"153","author":"Alzona M","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.58.6.683"},{"key":"e_1_2_1_25_2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.4049\/jimmunol.156.4.1387","article-title":"CD30 expression does not discriminate between human Thl\u2010 and Th2\u2010type T cells","volume":"156","author":"Hamann D","year":"1996","journal-title":"J Immunol"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(95)80092-1"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.6.2407"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90094-2"},{"key":"e_1_2_1_29_2","first-page":"339","article-title":"Circulating levels of soluble CD30, a marker of cells producing Th2\u2010 type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity","volume":"13","author":"Caligaris\u2010Cappio F","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_1_30_2","first-page":"413","article-title":"Soluble forms of p. 55\u2010IL\u20102R alpha, CD8 and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis","volume":"7","author":"Vinante F","year":"1994","journal-title":"Haematologica"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/148.1.237"},{"key":"e_1_2_1_32_2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4049\/jimmunol.157.1.441","article-title":"Stimulation of IgE and IgA production by CD45RA T helper cells in atopic patients","volume":"157","author":"Nasert S","year":"1996","journal-title":"J Immunol"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.6.575"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2222.1997.700840.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2222.1997.700840.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2222.1997.700840.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T15:24:08Z","timestamp":1698420248000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2222.1997.700840.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1997,7]]}},"alternative-id":["10.1046\/j.1365-2222.1997.700840.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2222.1997.700840.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,7]]}}}